Alzheimer’s Association Releases Dementia Care Practice Recommendations For End-Of-Life Care
The Alzheimer’s Association released its third set of Dementia Care Practice Recommendations for Assisted Living Residences and Nursing Homes. The Recommendations focus on improving the end of life experience for people with Alzheimer’s and other dementias by offering concrete suggestions for addressing issues unique to people with dementia at the end of life. [click link for full article]

Effectiveness Of Mouse Breeds That Mimic Alzheimer’s Disease Symptoms Questioned
Scientists have shown that recently developed mouse breeds that mimic the symptoms of Alzheimer’s disease (AD) may not be as effective as previously assumed. Sascha Weggen, Professor of Molecular Neuropathology at Heinrich-Heine-University, Duesseldorf, Germany; lead author Eva Czirr, Ph.D. [click link for full article]

New Data Highlights Long Term Tolerability And Sustained Benefits Of The Exelon Patch In The Treatment Of Alzheimer’s Disease
Exelon (rivastigmine transdermal patch), which delivers rivastigmine to patients through the skin into the bloodstream, has been shown to be well tolerated by Alzheimer’s disease (AD) patients for up to one year of treatment with sustained benefits. The findings come from the 28-week, open-label extension phase of the IDEAL ( I nvestigation of trans D ermal E xelon in Alz heimer’s disease) trial. [click link for full article]

A Few Different Ways to Prevent Alzheimer’s
A Few Different Ways to Prevent Alzheimer’s Alzheimer’s disease robs millions of people each year of their memories, their personalities, and the ability to complete daily activities. For the longest time, it was believed that nothing could be done to prevent this awful disease; that it was simply something that people had to look […]

Understanding Degrading Of Brain Network May Help Prevent Or Slow Memory Decline
Columbia University Medical Center researchers have identified a brain network within the frontal lobe that is associated with cognitive reserve, the process that allows individuals to maintain function despite brain function decline due to aging or Alzheimer’s disease. [click link for full article]

Sniff Test May Signal Disorders’ Early Stages
Measuring how deeply people inhale could alert doctors to the onset of neurodegenerative disorders like Alzheimer’s and Parkinson’s.

UK Inquiry Into Mental Health And Well-Being In Later Life Report ‘Improving Services And Support For Older People With Mental Health Problems
Response from Dr David Anderson, chair of the Faculty of Old Age Psychiatry, The Royal College of Psychiatrists “This important report reminds us that dementia is not the only serious mental health problem affecting older people. Depression, a life threatening condition and the most common cause of suicide, is three times more common than dementia. [click link for full article]

Effective Drug Treatment for Alzheimer’s
Effective Drug Treatment for Alzheimer’s Is there such as thing as an effective drug treatment for Alzheimer’s disease? To make that determination we must look at the disease itself. Basically, there are two types of drugs that are used in the treatment […]

Alzheimer’s Support Group: Others Who Care
Alzheimer’s Support Group: Others Who Care Alzheimer’s disease is a degenerative brain disorder that affects memory, behavior, and the normal thought process, and is a very real concern for anyone getting older. Of course, just because someone is losing their […]

Methods for Alzheimer’s Testing
Methods for Alzheimer’s Testing If you think a loved one is starting to become senile or experience other symptoms of dementia, you may want that person to undergo Alzheimer’s testing. Unfortunately, there is currently no definitive test for Alzheimer’s disease that a person can undergo. The only way doctors diagnose […]

Antihistamine Shows Promise in Treating Alzheimer’s
Dimebon, a drug long used as an antihistamine in Russia, is showing what some say are surprisingly strong results in treating Alzheimer’s disease.

Senior Doctor “Disappointed” Over Charity’s Legal Challenge Against NICE, UK
In this week’s BMJ, a senior doctor describes his disappointment with the Alzheimer’s Society’s recent alliance with drug makers in bringing the first legal challenge to judgements reached by the National Institute for Health and Clinical Excellence (NICE), the body that recommends which drugs are available on the NHS in England and Wales.On 10 August, the High Court ruled against the alliance and upheld NICE’s decision to limit treatments for Alzheimer’s disease. [click link for full article]

Dementia Drug Gains Approval
A skin patch to treat the dementia suffered by Alzheimer’s patients has gained federal approval, a drug company said.

Info on Alzheimer’s Disease to Share with Kids
Info on Alzheimer’s Disease to Share with Kids Someone in your family has Alzheimer’s disease, and you’ve been gathering info on Alzheimer’s disease to try to help you make decisions about what to do next, but everything you find is so scientific and complicated. What can […]